title: Functional validation confirms genomic phenotypes of glioblastoma with implications for targeted therapy.
authors.forename: Andrew T
authors.initials: AT
authors.lastname: Parsa
mesh_terms: D000818:Animals; D001932:Brain Neoplasms / Q000235:genetics* / Q000473:pathology* / Q000628:therapy; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics / Q000378:metabolism; D005819:Genetic Markers / Q000235:genetics*; D005909:Glioblastoma / Q000235:genetics* / Q000473:pathology* / Q000628:therapy; D006801:Humans; D051379:Mice; D058990:Molecular Targeted Therapy / Q000379:methods*; D010641:Phenotype; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000096:biosynthesis / Q000235:genetics
chemical_list: D019941:Cyclin-Dependent Kinase Inhibitor p16; D005819:Genetic Markers; D020796:Receptor, Platelet-Derived Growth Factor alpha